Business Context and Reporting Period
Company: Standard BioTools Inc. (Nasdaq: LAB)
Filing Type: Form 8-K (Current Report)
Date of Report: February 26, 2025
Reporting Period: This filing announces financial results for the three months and fiscal year ended December 31, 2024. The detailed results are contained in a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for specific data. Consequently, the filing text itself does not provide clear values for the following metrics:
- Revenue: Not stated in the cover text.
- Profit/Loss: Not stated in the cover text.
- Cash Flow: Not stated in the cover text.
- Margins: Not stated in the cover text.
- Debt and Liquidity: Not stated in the cover text.
Material Changes
The filing text does not contain specific numerical comparisons or descriptions of material changes versus prior periods. Investors must refer to the attached press release (Exhibit 99.1) for year-over-year or quarter-over-quarter performance analysis.
Guidance, Outlook, and Management Commentary
Forward-Looking Information: The filing explicitly incorporates by reference the "Full Year 2025 Revenue Outlook" and "About Standard BioTools Inc." sections from the attached press release under Item 7.01 (Regulation FD Disclosure).
Disclaimer: The document includes a standard forward-looking statement disclaimer. The information furnished in Items 2.02 and 7.01 is not deemed "filed" under Section 18 of the Exchange Act for liability purposes.
Investor Verification Checklist
- Exhibit 99.1: Review the attached press release for actual revenue, net income, and cash flow figures for Q4 and Full Year 2024.
- 2025 Guidance: Verify the specific "Full Year 2025 Revenue Outlook" numbers referenced in the filing.
- Non-GAAP Measures: Check the press release for any reconciliation of non-GAAP financial measures to GAAP.
- Risk Factors: Review the press release for any new risks or contingencies disclosed alongside the results.